This medical research company leverages a modified CRISPR gene-editing technique known as base editing to precisely target and modify genetic mutations that cause chronic disease and congenital disorders.
Anyone following or invested here? Up 77% in the past month
but I invested in Jan 21 and I’m still 18% down
Heh - pretty similar here. -26%. Havent seen any major news recently